Editor's Preface: Antidepressants of the Future
暂无分享,去创建一个
Existing antidepressants are unsatisfactory: they have limited efficacy, side-effects are a problem, and there is an appreciable degree of toxicity. However, nonpharmacological, psychological approaches to the treatment of depression also have their own drawbacks, so that the search for better antidepressant compounds continues.
[1] D. Nutt,et al. Monoamine Oxidase Inhibitors: Rehabilitation from Recent Research? , 1989, British Journal of Psychiatry.
[2] A. Altamura,et al. The Evidence for 20 mg a day of Fluoxetine as the Optimal Dose in the Treatment of Depression , 1988, British Journal of Psychiatry.
[3] P. Benfield,et al. Fluvoxamine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in depressive illness. , 1986, Drugs.